A data preprocessing strategy for metabolomics to reduce the mask effect in data analysis

Frontiers in Molecular Biosciences

Volumn 2, Issue FEB, 2015, Pages

  Yang, Jun ^a,b   Zhao, Xinjie ^a   Lu, Xin ^a   Lin, Xiaohui ^c   Xu, Guowang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Biomarkers; Data preprocessing; Differential metabolites; Metabolomics; Pattern recognition

Indexed keywords

EID: 84995547307     PISSN: None     EISSN: 2296889X     Source Type: Journal    
DOI: 10.3389/fmolb.2015.00004     Document Type: Article

References (38)

1. Abate-Shen, C., and Shen, M. M. (2009). Diagnostics: the prostate-cancer metabolome. Nature 457, 799-800. doi: 10.1038/457799a
2. Bijlsma, S., Bobeldijk, I., Verheij, E. R., Ramaker, R., Kochhar, S., Macdonald, I. A., et al. (2006). Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal. Chem. 78, 567-574. doi: 10.1021/ac051495j
3. Brindle, J. T., Antti, H., Holmes, E., Tranter, G., Nicholson, J. K., Bethell, H. W., et al. (2002). Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med. 8, 1439-1444. doi: 10.1038/nm1202-802
4. Craig, A., Cloarec, O., Holmes, E., Nicholson, J. K., and Lindon, J. C. (2006). Scaling and normalization effects in NMR spectroscopic metabonomic data sets. Anal. Chem. 78, 2262-2267. doi: 10.1021/ac0519312
5. Dai, W., Yin, P., Zeng, Z., Kong, H., Tong, H., Xu, Z., et al. (2014). Nontargeted modification-specific metabolomics study based on liquid chromatography-high-resolution mass spectrometry. Anal. Chem. 86, 9146-9153. doi: 10.1021/ac502045j
6. Enot, D. P., Lin, W., Beckmann, M., Parker, D., Overy, D. P., and Draper, J. (2008). Preprocessing, classification modeling and feature selection using flow injection electrospray mass spectrometry metabolite fingerprint data. Nat. Protoc. 3, 446-470. doi: 10.1038/nprot.2007.511
7. Fiehn, O. (2002). Metabolomics-the link between genotypes and phenotypes. Plant Mol. Biol. 48, 155-171. doi: 10.1023/A:1013713905833
8. Hrydziuszko, O., and Viant, M. R. (2012). Missing values in mass spectrometry based metabolomics: an undervalued step in the data processing pipeline. Metabolomics 8, S161-S174. doi: 10.1007/s11306-011-0366-4
9. Kell, D. B. (2004). Metabolomics and systems biology: making sense of the soup. Curr. Opin. Microbiol. 7, 296-307. doi: 10.1016/j.mib.2004.04.012
10. Kell, D. B., and Goodacre, R. (2014). Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery. Drug Discov. Today 19, 171-182. doi: 10.1016/j.drudis.2013.07.014
11. Keun, H. C. (2006). Metabonomic modeling of drug toxicity. Pharmacol. Ther. 109, 92-106. doi: 10.1016/j.pharmthera.2005.06.008
12. Keun, H. C., Ebbels, T. M. D., Antti, H., Bollard, M. E., Beckonert, O., Holmes, E., et al. (2003). Improved analysis of multivariate data by variable stability scaling: application to NMR-based metabolic profiling. Anal. Chim. Acta 490, 265-276. doi: 10.1016/S0003-2670(03)00094-1
13. Koh, Y., Pasikanti, K. K., Yap, C. W., and Chan, E. C. (2010). Comparative evaluation of software for retention time alignment of gas chromatography/time-of-flight mass spectrometry-based metabonomic data. J. Chromatogr. A 1217, 8308-8316. doi: 10.1016/j.chroma.2010.10.101
14. Kohl, S. M., Klein, M. S., Hochrein, J., Oefner, P. J., Spang, R., and Gronwald, W. (2012). State-of-the art data normalization methods improve NMR-based metabolomic analysis. Metabolomics 8, S146-S160. doi: 10.1007/s11306-011-0350-z
15. Lahdou, I. H., Oweira, M., Sadeghi, V., Daniel, G., Fusch, J. C., Schefold, G., et al. (2011). Tryptophan catabolites as prognostic biomarkers for the severity of chronic liver diseases in potential transplant recipients. Transplant Int. 24, 264-264
16. Mari, A., Lyon, D., Fragner, L., Montoro, P., Piacente, S., Wienkoop, S., et al. (2013). Phytochemical composition of L. analyzed by an integrative GC-MS and LC-MS metabolomics platform. Metabolomics 9, 599-607. doi: 10.1007/s11306-012-0473-x
17. Nicholson, J. K., Connelly, J., Lindon, J. C., and Holmes, E. (2002). Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1, 153-161. doi: 10.1038/nrd728
18. Pelczer, I. (2005). High-resolution NMR for metabomics. Curr. Opin. Drug Discov. Devel. 8, 127-133
19. Peterson, A. C., Balloon, A. J., Westphall, M. S., and Coon, J. J. (2014). Development of a GC/Quadrupole-Orbitrap mass spectrometer, part II: new approaches for discovery metabolomics. Anal. Chem. 86, 10044-10051. doi: 10.1021/ac5014755
20. Pinto, J., Domingues, M. R., Galhano, E., Pita, C., Almeida Mdo, C., Carreira, I. M., et al. (2014). Human plasma stability during handling and storage: impact on NMR metabolomics. Analyst 139, 1168-1177. doi: 10.1039/c3an02188b
21. Powers, R. (2014). The current state of drug discovery and a potential role for NMR metabolomics. J. Med. Chem. 57, 5860-5870. doi: 10.1021/jm401803b
22. Smilde, A. K., van der Werf, M. J., Bijlsma, S., van der Werff-van der Vat, B. J., and Jellema, R. H. (2005). Fusion of mass spectrometry-based metabolomics data. Anal. Chem. 77, 6729-6736. doi: 10.1021/ac051080y
23. Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., et al. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914. doi: 10.1038/nature07762
24. Sysi-Aho, M., Katajamaa, M., Yetukuri, L., and Oresic, M. (2007). Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinformatics 8:93. doi: 10.1186/1471-2105-8-93
25. Trygg, J., Holmes, E., and Lundstedt, T. (2007). Chemometrics in metabonomics. J. Proteome Res. 6, 469-479. doi: 10.1021/pr060594q
26. van den Berg, R. A., Hoefsloot, H. C. J., Westerhuis, J. A., Smilde, A. K., and van der Werf, M. J. (2006). Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7:142. doi: 10.1186/1471-2164-7-142
27. van Ravenzwaay, B., Montoya, G. A., Fabian, E., Herold, M., Krennrich, G., Looser, R., et al. (2014). The sensitivity of metabolomics versus classical regulatory toxicology from a NOAEL perspective. Toxicol. Lett. 227, 20-28. doi: 10.1016/j.toxlet.2014.03.004
28. Veselkov, K. A., Vingara, L. K., Masson, P., Robinette, S. L., Want, E., Li, J. V., et al. (2011). Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery. Anal. Chem. 83, 5864-5872. doi: 10.1021/ac201065j
29. Wachsmuth, C. J., Dettmer, K., Lang, S. A., Mycielska, M. E., and Oefner, P. J. (2014). Continuous water infusion enhances atmospheric pressure chemical ionization of methyl chloroformate derivatives in gas chromatography coupled to time-of-flight mass spectrometry-based metabolomics. Anal. Chem. 86, 9186-9195. doi: 10.1021/ac502133r
30. Wagner, L., Trattner, S., Pickova, J., Gomez-Requeni, P., and Moazzami, A. A. (2014). (1)H NMR-based metabolomics studies on the effect of sesamin in Atlantic salmon (Salmo salar). Food Chem. 147, 98-105. doi: 10.1016/j.foodchem.2013.09.128
31. Wang, Y., Tang, H., Holmes, E., Lindon, J. C., Turini, M. E., Sprenger, N., et al. (2005). Biochemical characterization of rat intestine development using high-resolution magic-angle-spinning 1H NMR spectroscopy and multivariate data analysis. J. Proteome Res. 4, 1324-1329. doi: 10.1021/pr050032r
32. Want, E., and Masson, P. (2011). Processing and analysis of GC/LC-MS-based metabolomics data. Methods Mol. Biol. 708, 277-298. doi: 10.1007/978-1-61737-985-7_17
33. Wold, S., Antti, H., Lindgren, F., and Ohman, J. (1998). Orthogonal signal correction of near-infrared spectra. Chemometr. Intell. Lab. Syst. 44, 175-185. doi: 10.1016/S0169-7439(98)00109-9
34. Worley, B., and Powers, R. (2014). MVAPACK: a complete data handling package for NMR metabolomics. ACS Chem. Biol. 9, 1138-1144. doi: 10.1021/cb4008937
35. Yang, J., Xu, G., Zheng, Y., Kong, H., Pang, T., Lv, S., et al. (2004). Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 813, 59-65. doi: 10.1016/j.jchromb.2004.09.032
36. Yang, J., Xu, G., Zheng, Y., Kong, H., Wang, C., Zhao, X., et al. (2005). Strategy for metabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. A 1084, 214-221. doi: 10.1016/j.chroma.2004.10.100
37. Yang, J., Zhao, X., Liu, X., Wang, C., Gao, P., Wang, J., et al. (2006). High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J. Proteome Res. 5, 554-561. doi: 10.1021/pr050364w
38. Zhao, X., Xu, F., Qi, B., Hao, S., Li, Y., Li, Y., et al. (2014). Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry. J. Proteome Res. 13, 1101-1111. doi: 10.1021/pr401130w